Suggestions
Joseph Farrell
Chief Product Officer
Professional Background
Joseph Farrell is a seasoned Chief Product Officer with over 20 years of diverse experience in operations, data analytics, and marketing. His extensive career includes ten fruitful years at BiTE Interactive where he has pioneered a strategic process intertwining Jobs-to-be-Done methodology with Lean Startup and Switch Interviews principles. Joseph’s passion lies in uncovering the hidden emotional and social jobs that customers seek fulfillment from when selecting products. His innovative approach has paved the way for successful product developments across high-profile clients including NASA, Gibraltar Ventures, H&R Block, Nestlé, Infiniti, and Prudential, allowing him to secure nine features in the App Store from Apple.
Joseph’s management experience is extensive, having served as a project manager for prestigious organizations such as Lexus, Toyota, and the U.S. Army, demonstrating his versatility in navigating both corporate and governmental frameworks. Notably, he has overseen a substantial interactive budget of $6.5 million at Acura.com as a Program Manager, enabling him to drive significant growth and innovation across multiple channels.
In addition to his robust product management skills, Joseph is on the Cucumber (BDD) Advisory Board alongside the BDD methodology inventor, Aslak Hellesøy, showcasing his commitment to advancing best practices in behavior-driven development.
Education and Achievements
Joseph earned a Master’s Degree in Teacher Education from the University of Dayton, along with a Bachelor’s Degree in American History, further enriching his analytical capabilities with a strong educational foundation. His unique blend of educational background and professional experiences allows him to approach product development and marketing strategies from a well-rounded perspective.
His writings and thought leadership have made a significant impact in the field of mobile technology; as a blogger on Mobile Surge, Joseph provides insights and strategies that resonate with entrepreneurs and corporate leaders alike. His contributions extend to prominent platforms such as the Huffington Post and Wired, where his articles serve to educate others on the nuances of mobile startups, product management, and the interplay of data within marketing strategies.
In 2020, he published his book, "The Long Road: Going from Concept to Traction to Scale with Your Mobile Startup," which has been a valuable resource for many aspiring entrepreneurs looking to navigate their journey in the mobile market and achieve sustainable growth.
Achievements
- Led notable product developments for clients such as NASA and Prudential, enhancing their market offerings and achieving robust engagement.
- Received recognition for nine distinct features in the Apple App Store, highlighting the quality and impact of the products developed under his guidance.
- Instrumental in implementing Agile methodologies that fully embrace Behavior-Driven Development within teams, boosting overall productivity and satisfaction.
- Featured expert contributor on multiple high-traffic blogs and publications that address technology, product management, and marketing analytics.
- Passionate advocate for data-driven decision-making in marketing, having successfully tested traction for multiple startups, including GamePlans, through sophisticated marketing strategies utilizing programmatic and social media techniques.
Highlights
It’s incredible to see how the investments in mRNA technology for COVID-19 have paved the way for groundbreaking advancements in other areas of medicine. The $20 billion spent not only helped save countless lives during the pandemic but also spurred significant interest and further investment in mRNA technology for a wide range of diseases, including cancer. The launch of the phase 1 clinical trial for the mRNA lung cancer vaccine, BNT116, across 34 research sites in seven countries is a huge step forward. It's exciting to think about the potential impact this could have on cancer treatment and beyond.
In 2000, I was diagnosed with Lasik-induced corneal neuralgia, a progressive, debilitating condition characterized by extreme burning, light sensitivity, and foreign object sensations for which there was no cure and no treatments. Last summer, I went to Dr. Kristina Voss at USC’s Keck Medical Center, hoping for some relief. Dr. Voss suggested off-label Oxervate, a new drug that treats neurotrophic keratitis (NK) by regrowing the corneal nerves. Kaiser was dedicated to their patients enough to approve this expensive experimental treatment. In just six weeks, I was completely cured of 23 years of suffering—no burning, no pain, no redness, no corneal neuralgia.
The power of medical interventions to save lives and end suffering is real. Every day, I am so thankful to everyone who helps advance health sciences and am grateful to be a part of this process.
#cornealneuralgia #LASIK #OXERVATE #USC #Keck #Kaiser #HealthSciences
